Completed the analysis and wrote the outputs to [analysis_report.md](/var/folders/j_/dt6mk_nd7tbfpyx2v5z_lv6c0000gn/T/tmp.rGNfIWzj1W/analysis_report.md) and [plots](/var/folders/j_/dt6mk_nd7tbfpyx2v5z_lv6c0000gn/T/tmp.rGNfIWzj1W/plots).

The dataset is clean structurally: 800 patients, no missing values, no duplicate IDs, and 3 zero-time event rows that were handled explicitly for survival modeling. The data are most appropriately analyzed as time-to-event data, so I used Kaplan-Meier curves, log-rank tests, a multivariable Cox model, proportional hazards diagnostics, and a Weibull AFT sensitivity model.

The main result is strong and consistent: `Drug_B` is associated with substantially better survival than `Drug_A` both unadjusted and adjusted. In the Cox model, `Drug_B` had HR `0.510` with 95% CI `0.428` to `0.607` and `p = 3.71e-14`. Other covariates in this dataset, including age, sex, stage, and biomarker, were not statistically convincing after adjustment. Model discrimination was moderate (`CV c-index ≈ 0.597`), and the proportional hazards checks did not show meaningful violations.

I also saved these PNGs in [plots](/var/folders/j_/dt6mk_nd7tbfpyx2v5z_lv6c0000gn/T/tmp.rGNfIWzj1W/plots): `numeric_distributions.png`, `group_boxplots.png`, `stacked_bars.png`, `correlation_heatmap.png`, `km_treatment.png`, `km_stage.png`, and `cox_forest_plot.png`.

For reproducibility, the analysis pipeline is in [analyze_dataset.py](/var/folders/j_/dt6mk_nd7tbfpyx2v5z_lv6c0000gn/T/tmp.rGNfIWzj1W/analyze_dataset.py).